NEUBASE THERAPEUTICS INC

CUSIP: 64132K102 Class: COM

GEODE CAPITAL MANAGEMENT, LLC's Holding History (CIK: 0001214717)

Note: Option positions (PUT/CALL) are excluded.

Q1 2023
Shares 233,973 Value ($000) $43 Avg Close — Range —
Q4 2022
Shares 233,973 Value ($000) $0 Avg Close — Range —
Q3 2022
Shares 234,571 Value ($000) $92 Avg Close — Range —
Q2 2022
Shares 234,571 Value ($000) $246 Avg Close — Range —
Q1 2022
Shares 243,984 Value ($000) $458 Avg Close — Range —
Q4 2021
Shares 243,984 Value ($000) $685 Avg Close — Range —
Q3 2021
Shares 239,819 Value ($000) $865 Avg Close — Range —
Q2 2021
Shares 233,856 Value ($000) $1,120 Avg Close — Range —
Q1 2021
Shares 315,525 Value ($000) $2,331 Avg Close — Range —
Q4 2020
Shares 253,930 Value ($000) $1,774 Avg Close — Range —
Q3 2020
Shares 239,117 Value ($000) $1,814 Avg Close — Range —
Q2 2020
Shares 152,486 Value ($000) $1,338 Avg Close — Range —
Q1 2020
Shares 16,206 Value ($000) $115 Avg Close — Range —
Q4 2019
Shares 16,206 Value ($000) $116 Avg Close — Range —
Q3 2019
Shares 15,960 Value ($000) $79 Avg Close — Range —